Skip to content
Search

Latest Stories

Darzi report reveals NHS is in critical condition, pharmacy bodies urge immediate action

Darzi report reveals NHS is in critical condition, pharmacy bodies urge immediate action

Pharmacy organisations are hopeful that the Darzi report will prompt ministers to take swift action to tackle the chronic underfunding that is driving pharmacy closures 

The Department of Health and Social Care (DHSC) has published Lord Darzi's report on the state of NHS England, which revealed that the health service is in "serious trouble."


Lord Darzi pointed out that the NHS has failed to meet key promises made to the public since 2015 and patient satisfaction is now at its lowest ever level.

Rising waiting times and difficulties accessing GPs were highlighted as major concerns.

“There are huge and unwarranted variations in the number of patients per GP, and shortages are particularly acute in deprived communities,” the report said.

Darzi described the state of A&E as “awful”, noting that nearly 10 per cent of patients wait 12 hours or more today.

Additionally, Lord Darzi's investigation found that the NHS budget is not being optimally allocated, noting that “too great a share is being spent in hospitals, too little in the community, and productivity is too low.”

The report identified four inter-related factors contributing to the NHS current dire state:

  1. Austerity in funding and capital starvation
  2. The impact of the Covid-19 pandemic and its aftermath
  3. Lack of patient voice and staff engagement
  4. Inefficient management structures and systems

Despite these challenges, Darzi remains optimistic about the NHS's future as he concluded that the “NHS is in critical condition, but its vital signs are strong.”

He acknowledged the massive gap in capital investment but noted that the NHS has more resources than ever.

However, he warned that restoring the NHS to peak performance will take time and will likely extend beyond a single parliamentary term.

Reaction from pharmacy bodies

Pharmacy organisations are hopeful that the report’s findings will prompt ministers to take swift action to tackle the chronic underfunding that is driving pharmacy closures.

Paul Rees, Chief Executive of the National Pharmacy Association (NPA), said: “Lord Darzi’s report must spur Ministers into immediate action to end the scandal of pharmacy closures caused by chronic underfunding over many years, that is eating away at frontline patient care.

“With pharmacies closing at the rate of seven a week and so many more teetering on the brink, the millions who use pharmacies simply can’t wait. They need action now.”

He emphasised that modest investment to ensure adequate pharmacy funding could “transform frontline care, end the scramble for doctors’ appointments, and help fix the NHS fast.”

Malcolm Harrison, Chief Executive of the Company Chemists’ Association (CCA), welcomed the report's findings and its acknowledgment of the critical state of NHS and community pharmacy.

Harrison highlighted the severe impact of a 30 per cent real terms cut in funding since 2015, which led to the closure of over 1,200 pharmacies.

He stressed that, unlike the NHS, the productivity in the community pharmacy has increased, despite a shrinking funding pot.

“Between 2017/18 and 2023/24, the number of items dispensed each year grew by over 100m. In the same period, the number of clinical services delivered in community pharmacies increased by over 115 per cent with community pharmacies delivering over 12m services in 2023/24.”

“The review rightly points out that there is huge potential to harness the clinical capabilities of pharmacists. Expansion of Pharmacy First, which the report describes as a “notable success” is key – a fully-fledged service could free up 30m+ GP appointments each year.

Similarly, pharmacies can play an even bigger role in administering vaccinations as the report rightly highlights concerns around declining uptake.”

However, he noted that an expanded role for community pharmacy is only possible if there is action to protect the existing community pharmacy network through additional investment.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less